Global IV(intravenous) Port Market Size By Type (Fixed Base Type, Mobile Base Type), By Application (Hospital, Outpatient Service), By Region, And Segment Forecasts, 2023 to 2032

The Global IV (Intravenous) Port Market was valued at USD 1.9 billion in 2023 and is projected to reach USD 3.4 billion by 2031, growing at a CAGR of 7.4% during the forecast period from 2023 to 2031. The market’s growth is primarily driven by the increasing prevalence of chronic diseases such as cancer and cardiovascular disorders, the rise in chemotherapy procedures, and the growing demand for long-term intravenous therapy. IV ports offer a reliable, safe, and efficient method for administering medications, fluids, and nutrients, especially in patients requiring prolonged treatment.

As healthcare systems globally emphasize improved patient outcomes and quality of life, the adoption of IV ports is expected to accelerate, particularly in oncology and critical care settings.

Drivers:

1. Rising Incidence of Chronic Illnesses:

The growing burden of chronic diseases like cancer, renal failure, and diabetes is fueling the demand for long-term vascular access solutions, such as IV ports, which offer reduced infection risks and enhanced patient comfort.

2. Technological Advancements in Port Devices:

Innovations in port design, including antimicrobial coatings, power-injectable ports, and minimally invasive insertion techniques, are driving market adoption by enhancing safety and procedural efficiency.

3. Increasing Preference for Outpatient and Home-Based Treatment:

Healthcare trends are shifting towards outpatient care and home infusion therapies, wherein IV ports play a critical role by enabling repeat access without repeated needle sticks.

Restraints:

1. High Cost of Port Implantation and Maintenance:

The initial cost of IV ports, combined with surgical implantation and post-operative care, can be significant, especially in developing regions with limited healthcare budgets.

2. Risk of Complications:

Despite technological improvements, risks such as catheter-related bloodstream infections (CRBSIs), thrombosis, and device malfunction remain a challenge, potentially limiting widespread adoption.

Opportunity:

1. Expansion in Emerging Healthcare Markets:

Countries across Asia-Pacific and Latin America are investing in oncology and chronic disease management, presenting significant opportunities for IV port market penetration.

2. Growing Use in Pediatric and Geriatric Care:

As specialized medical care for vulnerable populations improves, the use of IV ports for long-term therapeutic access in pediatric and elderly patients is expected to rise.

Market by System Type Insights:

By system type, Single-Lumen IV Ports held the largest market share in 2023. These ports are widely preferred in oncology due to ease of insertion and lower complication rates. However, Dual-Lumen IV Ports are expected to witness faster growth during the forecast period, driven by their ability to deliver multiple therapies simultaneously, making them ideal for intensive care units and complex treatment regimens.

Market by End-Use Insights:

In terms of end-use, Hospitals dominated the market in 2023, accounting for more than 55% of the revenue. This dominance is attributed to the high volume of surgical implantations and oncology treatments administered in hospital settings. Ambulatory Surgical Centers (ASCs) and Home Healthcare settings are projected to grow rapidly due to increasing preference for cost-effective and patient-centric care models.

Market by Regional Insights:

Geographically, North America led the global IV port market in 2023, supported by robust healthcare infrastructure, high disease prevalence, and early adoption of innovative medical technologies. Asia-Pacific is anticipated to exhibit the highest growth rate during the forecast period due to rising healthcare spending, improving access to treatment, and increasing awareness about IV port benefits in countries like China and India.

Competitive Scenario:

Key players operating in the Global IV Port Market include Becton, Dickinson and Company (BD), AngioDynamics, Smiths Medical, Teleflex Incorporated, B. Braun Melsungen AG, ICU Medical Inc., and Medtronic plc. These companies are focusing on product innovation, strategic collaborations, and regional expansions to enhance their market share.

In 2023, BD introduced a new antimicrobial-coated IV port designed to reduce infection risk during long-term therapy.

Teleflex expanded its vascular access product line in 2024 through a strategic acquisition aimed at enhancing its footprint in emerging markets.

In 2025, AngioDynamics received FDA clearance for its next-generation power-injectable port system, improving efficiency for imaging procedures and drug delivery.

Scope of Work – Global IV (Intravenous) Port Market

Report Metric Details

Market Size (2023) USD 1.9 billion

Projected Market Size (2031) USD 3.4 billion

CAGR (2023–2031) 7.4%

Market Segments System Type (Single-Lumen, Dual-Lumen), End-Use (Hospitals, ASCs, Home Healthcare), Region

Growth Drivers Rising chronic disease prevalence, technological advancements, demand for outpatient care

Opportunities Expansion in emerging markets, pediatric and geriatric care uptake

Key Market Developments:

2023: BD launched a new generation of infection-resistant ports integrated with silver-based antimicrobial technology.

2024: Smiths Medical entered a partnership with oncology clinics in Europe to expand the deployment of dual-lumen IV ports.

2025: ICU Medical introduced a telemonitoring-compatible port that allows clinicians to track infusion parameters remotely.

FAQs:

1) What is the current market size of the Global IV (Intravenous) Port Market?

The market size was valued at USD 1.9 billion in 2023.

2) What is the major growth driver of the Global IV (Intravenous) Port Market?

The primary growth driver is the increasing prevalence of chronic diseases requiring long-term vascular access.

3) Which is the largest region during the forecast period in the Global IV (Intravenous) Port Market?

North America held the largest market share in 2023 and is expected to maintain dominance.

4) Which segment accounted for the largest market share in Global IV (Intravenous) Port Market?

The Single-Lumen IV Port segment led the market in 2023.

5) Who are the key market players in the Global IV (Intravenous) Port Market?

Key players include Becton, Dickinson and Company, AngioDynamics, Smiths Medical, Teleflex, and B. Braun.